Fingerprint
Dive into the research topics of 'A phase II trial of gefitinib in patients with non-metastatic hormone-refractory prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II trial of gefitinib in patients with non-metastatic hormone-refractory prostate cancer
Eric J. Small, Joseph Fontana, Nizar Tannir, Robert S. Dipaola, George Wilding, Mark Rubin, Renee Bailey Iacona, Fairooz F. Kabbinavar
Research output: Contribution to journal › Article › peer-review
62
Scopus
citations